Home Go to http://www.treatHIV.com
Bibliography HomeBoardAboutContact
 

Perspectives and OpinionsMutation and Drug DataAsk the ExpertsTest InfoFrom the PodiumDaily Resistance NewsBest of SiteArchive
Zidovudine phosphorylation detemined at intervals over 12 months in naïve and antiretroviral experienced HIV+patients.
Originally Published on January 1, 1998

Back DJ, Hoggard PG, Gibbons SE, Lloyd J, Khoo SH, Wilkins EG, Merry C, Barry MG.

5th Conference on Retroviruses and Opportunistic Infections, February 1-5, 1998, Chicago, Illinois. LB 10 page 224.

ABSTRACT:
Nucleoside analogues (NA) require intracellular phosphorylation to the active triphosphate prior to the inhibition of HIV replication. Emergence of viral drug resistance is a central problem for the success of antiviral therapy and while the main focus has been a virological mechanism of resistance it is important to consider that pharmacological mechanisms (i.e. decreased intracellular phosphorylation of NA with time) may play a key role. We have determined the intracellular concentrations of ZDV and its mono-, di-, and tri- phosphates in PNMCs at intervals over 12 months in HIV+ patients receiving combination therapy of ZDV/ddl or ZDV/3TC. Twenty four subjects (both antiretroviral naïve and ZDV experienced) have been recruited and blood samples collected at 0, 1, 2, 3, 6, 9 and 12 months. Intracellular nucleotides are measured by a validated combined HPLC-RIA method. We report data on 10 patients who have completed the trial to 12 months.

There was no significant difference from baseline for either intracellular total ZDV phosphates (AUC 0-2 h, 2.05 1.47, 2.73 1.79, 2.20 1.46, 2.17 1.35, 1.83 0.95, 2.49 2.14, 1.56 0.89, 3.40 1.89 pmoles/10^{6} cells.h; mean s.d. at day 0, 2 weeks, 1, 2, 3, 6, 9 & 12 months) or ZDV triphosphate (0.08 0.05, 0.10 0.07, 0.09 0.08, 0.13 0.10, 0.09 0.07, 0.12 0.07, 0.06 0.05, 0.10 0.07 pmoles/10^{6} cells.h; mean s.d. at day 0,2 weeks, 1, 2, 3, 6, 9 & 12 months).

From this interim analysis there is no evidence of i) a systematic decrease in intracellular phosphorylation of ZDV with time or ii) a difference between naïve and experienced patients, suggesting that altered phosphorylation is not a key factor governing the emergence of resistance.

back to the top of this article
  Vertibrae
Copyright © 1997–2003, Vertibrae, Inc. and HIVresistanceWeb. All rights reserved.  |  Privacy Policy
RegisterLogin